Jose G. Van Den Berg

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids.

Journal: Molecular cancer

Published: February 27, 2026

Survival and prognostic differences between appendiceal NETs and goblet cell adenocarcinomas.

Survival and prognostic differences between appendiceal NETs and goblet cell adenocarcinomas.

Journal: Endocrine oncology (Bristol, England)

Published: March 12, 2025

Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers.

Neoadjuvant immunotherapy in mismatch-repair-proficient colon cancers.

Journal: Nature

Published: January 23, 2025

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.

Journal: Nature medicine

Published: July 29, 2024

Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer.

Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer.

Journal: The New England journal of medicine

Published: June 05, 2024

Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.

Author Correction: Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial.

Journal: Nature medicine

Published: March 06, 2024

Karyotype evolution in response to chemoradiotherapy and upon recurrence of esophageal adenocarcinomas.

Karyotype evolution in response to chemoradiotherapy and upon recurrence of esophageal adenocarcinomas.

Journal: Cell reports

Published: February 28, 2024

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.

Journal: Nature medicine

Published: February 02, 2024

Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid.

Improving diagnostic accuracy of identifying gastric cancer patients with peritoneal metastases: tumor-guided cell-free DNA analysis of peritoneal fluid.

Journal: Oncogene

Published: November 28, 2023

Intraoperative frozen section of subareolar tissue in nipple-sparing mastectomy: Towards a less is more approach.

Intraoperative frozen section of subareolar tissue in nipple-sparing mastectomy: Towards a less is more approach.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: November 08, 2023

International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy.

International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 03, 2023

Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics.

Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: July 17, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026